a clinical-stage biopharmaceutical company developing tumour immunotherapy
Industry Biotechnology
A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with VIR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then VIR could also see price increases.
Ticker / NAME | Correlation To CVAC | 1D Price Change % | ||
---|---|---|---|---|
CVAC | 100% | -2.91% | ||
VIR - CVAC | 35% Loosely correlated | -3.79% | ||
BNTX - CVAC | 33% Poorly correlated | -7.10% | ||
BLUE - CVAC | 31% Poorly correlated | -3.64% | ||
OABI - CVAC | 30% Poorly correlated | N/A | ||
NAUT - CVAC | 29% Poorly correlated | -0.40% | ||
More |
Ticker / NAME | Correlation To CVAC | 1D Price Change % |
---|---|---|
CVAC | 100% | -2.91% |
germany theme (2 stocks) | 52% Loosely correlated | -4.54% |
biopharmaceutical theme (10 stocks) | 22% Poorly correlated | -7.05% |